HomeREGULATORY
REGULATORY

Japan’s “NDB” Insurance Claim Database Corroborates Slack SGLT-2 Prescriptions for Older People in FY2015
(Sep.26.2017)

By Reiji Anasako

The pharma industry has seen floundering sales of sodium-glucose co-transporter-2 (SGLT-2) inhibitors in Japan ever since their launch a few years ago. Now with recent statistics based on a national insurance claim database, dubbed NDB, it was revealed that doctors were indeed shying away from prescribing these medicines in the elderly age 75 and older amid swirling side effect concerns over the class ...
(LOG IN FOR FULL STORY)

News Calendar